Background: Later hypersensitivity is associated with occupational all
ergy, contact urticaria, rhinitis, asthma, and anaphylaxis. However, s
tandardized sensitive and specific latex extract for skin prick or ser
ologic testing is not available in the United States. Methods: We inve
stigated the reliability of two latex extracts in 118 consecutive skin
tests in patients with spina bifida, health care workers, and other p
atients with symptoms of latex allergy, and 10 control subjects. Resul
ts: Forty-two of 86 patients with spina bifida, 11 of 15 health care w
orkers with symptoms of later allergy, 6 of 7 patients with symptoms o
f latex allergy, and 0 of 10 control subjects had demonstrable immedia
te wheal and flare responses to latex prick testing. In addition, 95 p
atients and 10 control subjects were tested concurrently for latex-spe
cific IgE by ELISA. Of 55 patients with positive skin prick test resul
ts, 48 were reactive as determined by ELISA for IgE-specific latex ant
ibody (sensitivity = 87%). Latex ELISA titers were significantly highe
r in patients with positive skin prick test results with a history of
anaphylaxis to latex and in individuals without symptoms of latex alle
rgy who had positive skin prick test results when compared with patien
ts with negative skin prick test results. During the skin test procedu
re, nine patients had adverse reactions, including anaphylactic reacti
ons in four. Conclusions: Skin prick and serum testing are reliable me
thods of diagnosing latex allergy. Serologic evaluation may be more de
sirable until allergen standardization is available.